Significance Statement {#s1}
======================

The mechanisms underlying memory consolidation are not completely understood. Perineuronal nets (PNNs) are extracellular matrix (ECM) structures enveloping subsets of neurons and are involved in regulating synaptic plasticity. Recent studies indicate that PNNs are modified during learning to allow for formation of new synapses. During sleep, synapses are proposed to undergo modification as memory consolidation processes occur. Furthermore, microglia are involved in synaptic regulation and produce several proteases that cleave PNN components. We demonstrate that PNNs are modified in a circadian manner and coincide with expression rhythms of the protease cathepsin-S. These rhythms may contribute to altered synaptic plasticity reported during sleep, suggesting a key process through which proteases modify PNNs to allow for to memory consolidation.

Introduction {#s2}
============

Perineuronal nets (PNNs) are extracellular matrix (ECM) structures surrounding subpopulations of neurons. PNNs form during the end of critical periods of plasticity, marking their closure by conferring an adult form of restricted plasticity ([@B86]; [@B42]; [@B67]). Although PNNs have been historically considered stable structures, recent studies suggest they are modified during learning to allow for formation of synapses ([@B76]; [@B15]; [@B37]; [@B8]; [@B102]). An important line of evidence comes from studies on matrix metalloproteases, which cleave ECM components including chondroitin sulfate proteoglycans (CSPGs), key components of PNNs, and contribute to regulation of synaptic plasticity ([@B74]; [@B87]; [@B6]). Expression of these proteases contributes to fear learning and memory consolidation ([@B15]; [@B37]). These effects are mediated through dendritic spine remodeling ([@B107]) and regulation of long-term plasticity (LTP; [@B75]). In addition, increasing number of studies directly show that CSPGs, and in turn PNNs, are critically involved in the regulation of synaptic plasticity ([@B16]). Notably, the strength of LTP has been shown to vary in a circadian manner in the hippocampus ([@B20]), a region where PNN functions in regulating synaptic strength and stability have been particularly well characterized ([@B16]; [@B14]; [@B38]). Together, these observations support the hypothesis that PNN composition may be regulated in a circadian manner to allow for circadian rhythms in synaptic plasticity.

PNN composition is regulated by several cell types including astrocytes and neurons, which produce several of the core PNN components, along with a broad range of endogenous proteases that cleave PNN components produced primarily by astrocytes and microglia ([@B77]; [@B70]; [@B13]). We focus on the microglial protease cathepsin-S as a first step toward identifying molecules that may contribute to circadian rhythms in PNN composition. Cathepsin-S has been shown to regulate synaptic plasticity, cleave several ECM components, and is expressed diurnally in the rodent cortex ([@B85]; [@B48]). Furthermore, several lines of evidence suggest that microglia contribute to diurnal regulation of PNNs. Compelling data point to the role of microglia in the regulation of synaptic plasticity ([@B112]; [@B106]). Furthermore, microglial dysfunction in the hippocampus results in reduction of dendritic spines along with increased ECM expression ([@B12]), suggesting microglia participate in degrading the ECM to allow for increased synaptic plasticity. A recent study demonstrated that pharmacological depletion of microglia prevented PNN decreases that normally occur in a mouse model of Huntington's disease and improved memory function ([@B25]), suggesting that microglia play a critical role in regulating PNN composition. Taken together, the current evidence suggests that cathepsin-S from microglia is an optimal candidate for contributing to modification of PNN composition to allow dynamic regulation of synaptic plasticity during sleep.

PNNs are well represented in neural circuits involved in emotion processing and critically involved in the regulation of fear and reward memories ([@B42]; [@B101]; [@B8]; [@B56]). Consistent with these observations, PNNs have been implicated in several brain disorders involving these regions, including schizophrenia, bipolar disorder, Alzheimer's disease and addiction ([@B5]; [@B73]; [@B79], [@B81]; [@B67]; [@B116]; [@B101]; [@B105]; [@B11]). Several of these disorders also show altered sleep and circadian rhythms ([@B59]; [@B68]; [@B113]; [@B65]; [@B82]). Thus, diurnal modulation of PNNs has a broad range of implications for psychiatric disorders and memory processing.

We tested the hypothesis that PNNs vary in a circadian manner and that these rhythms are disrupted by sleep deprivation. In mice, we first assessed densities of PNNs across the 24-h cycle in brain regions involved in emotional memory processing and implicated in psychiatric disorders ([@B111]; [@B93]; [@B57]; [@B62]; [@B67]; [@B69]; [@B82]; [@B114]). We then assessed the relationship between PNNs and sleep by testing the effect of sleep deprivation on PNN densities in several regions including the hippocampus, a brain region in which diurnal differences in LTP were reported ([@B20]).

As a first step in testing the hypothesis that matrix proteases are involved in regulating PNN rhythmicity, we characterized rhythms of cathepsin-S expression. We then demonstrated that cathepsin-S impacts PNN integrity by incubating mouse sections in active cathepsin-S enzyme. Finally, we tested the hypothesis that PNN rhythmicity is conserved in humans, focusing on the amygdala and thalamic reticular nucleus (TRN), two regions in which PNN deficits in schizophrenia and bipolar disorder were reported ([@B79], [@B81]; [@B105]).

Materials and Methods {#s3}
=====================

Antibodies and lectin labeling {#s3A}
------------------------------

### *Wisteria floribunda* agglutinin (WFA) {#s3A1}

WFA (catalog \#B-1355, Vector Labs), a lectin isolated from seeds of *Wisteria floribunda*, binds specifically to *N*-acetyl-D-galactosamine on the terminal end of chondroitin sulfate (CS) chains, with a preference for β glycosidic linkage ([@B54]). The specificity of WFA as a marker for these macromolecules is supported by extensive literature, including ablation of labeling following CS enzymatic digestion ([@B36]; [@B79]).

### Cathepsin-S (E-3) {#s3A2}

Cathepsin-S E-3 (sc-271619, Santa Cruz Biotechnology Inc.) is a mouse monoclonal antibody raised against a peptide matching amino acids 302--331 at the C terminus of human cathepsin-S, shown to detect the 24-kDa form of cathepsin-S (sc-271619 data sheet, Santa Cruz Biotechnology Inc.).

### IBA1 {#s3A3}

IBA1 (019--19 741, FUJIFILM Wako Chemicals USA) is a rabbit polyclonal antibody raised against a synthetic peptide to the C terminus of IBA1, shown to detect the 17-kDa form of IBA1 in rat and mouse brain samples (019-19741 data sheet, FUJIFILM Wako Chemicals USA).

Immunocytochemistry (mouse samples) {#s3B}
-----------------------------------

Free-floating tissue sections were carried through antigen retrieval in citric acid buffer (0.1 [m]{.smallcaps} citric acid and 0.2 [m]{.smallcaps} Na~2~HPO~4~), heated to 80°C for 30 min, and incubated in biotinylated WFA lectin (catalog \#B-1355, Vector Labs) or the mouse monoclonal primary antibody anti-cathepsin-S (1:500, sc-271619, Santa Cruz Biotechnology Inc.) for 48 h, and subsequently in biotinylated secondary antibody (horse anti-goat IgG; 1:500; Vector Labs), followed by streptavidin conjugated with horse-radish peroxidase for 2 h (1:5000 μl, Zymed), and, finally, in nickel-enhanced diaminobenzidine/peroxidase reaction (0.02% diaminobenzidine, Sigma-Aldrich, 0.08% nickel-sulfate, 0.006% hydrogen peroxide in PB). All solutions were made in PBS with 0.2% Triton X-100 (PBS-Tx) unless otherwise specified. Immunostained sections were mounted on gelatin-coated glass slides, coverslipped, and coded for blinded quantitative analysis. All sections included in the study were processed simultaneously within the same session to avoid procedural differences. Omission of the primary or secondary antibodies did not result in detectable signal, and preabsorption of mouse anti cathepsin-S with 300 nanograms of active human cathepsin-S (SRP0292, Sigma-Aldrich) did not result in detectable immunolabeling signal.

Dual antigen immunofluorescence {#s3C}
-------------------------------

Sections were co-incubated in primary antibodies (cat-S, l:500 μl, rabbit anti-IBA1, l:1000 μl; FUJIFILM Wako, catalog \#019-19741); in 2% bovine serum albumin (BSA) for 72 h at 4°C. This step was followed by 4-h incubation at room temperature in Alexa Fluor goat anti-mouse 647 (1:300 μl; A-21235, Invitrogen) and donkey anti-rabbit 555 (1:300 μl; A-32 794, Invitrogen), 10-min incubation in DAPI 1:16 000 in 0.1 [m]{.smallcaps} PB, followed by 10 min in 1 m[m]{.smallcaps} CuSO~4~ solution (pH 5.0) to block endogenous lipofuscin autofluorescence ([@B95]). Sections were mounted and coverslipped using Dako mounting media (S3023, Dako).

Immunocytochemistry (human samples) {#s3D}
-----------------------------------

Free-floating tissue sections were carried through antigen retrieval in citric acid buffer (0.1 [m]{.smallcaps} citric acid and 0.2 [m]{.smallcaps} Na~2~HPO~4~), heated to 80°C for 30 min, and incubated in biotinylated WFA lectin (catalog \#B-1355, Vector Labs) for 48 h, followed by streptavidin conjugated with horse-radish peroxidase for 2 h (1:5000 μl, Zymed), and, finally, in nickel-enhanced diaminobenzidine/peroxidase reaction (0.02% diaminobenzidine, Sigma-Aldrich, 0.08% nickel-sulfate, 0.006% hydrogen peroxide in PB). All solutions were made in PBS-Tx unless otherwise specified. Immunostained sections were mounted on gelatin-coated glass slides, coverslipped, and coded for blinded quantitative analysis. All sections included in the study were processed simultaneously within the same session to avoid procedural differences. Omission of the WFA lectin or HRP-conjugated streptavidin did not result in detectable signal.

Data collection (mouse) {#s3E}
-----------------------

In mouse brain samples, serial sections containing the hippocampus, infralimbic cortex, prelimbic cortex, TRN, and habenula were quantified using a Leica microscope interfaced with Bioquant Nova Prime v6.0 (R&M Biometrics). Borders of each region were defined according to the Allen Brain Atlas and traced under 4× magnification. Each traced region was systematically scanned through the full *x*-, *y*-, and *z*-axes under 40× magnification to count each WFA+ PNN or cathepsin-S-immunoreactive (IR) microglial cell.

Dual immunofluorescence sections labeled for cathepsin-S and IBA1 from three adult male mice housed in a standard light-dark cycle (four sections per mouse) and killed at zeitgeber time (ZT)6 were quantified using Stereo-Investigator Image Analysis System (v.10.0; MBF Biosciences), interfaced with an Olympus BX-61 microscope. Cathepsin-S-IR cells were distinguished from cathepsin-S-IR blood vessels by the presence or absence of DAPI-stained nuclei.

Data collection (human) {#s3F}
-----------------------

In human postmortem samples, total numbers and numerical densities of PNNs labeled with WFA were quantified using stereology based sampling ([@B78]; [@B29]) in the amygdala and TRN in a cohort of postmortem brain samples from human subjects (14 amygdala, 15 TRN subjects). WFA-labeled (WFA+) PNNs were counted in the lateral (LN), basal (BN), accessory basal (AB), and cortical (CO) nuclei of the amygdala, and in TRN using a Zeiss Axioskop-2 Plus interfaced with Stereo-Investigator 6.0 (Microbrightfield Inc.). Intrarater (H.P. and M.A.) reliability of at least 95% was established before formal data collection and reassessed regularly. The borders of amygdala nuclei were traced and confirmed in adjacent Nissl-stained sections according to cytoarchitectonic criteria described previously ([@B100]; [@B3]). The nomenclature adopted was used by [@B103]. The central, medial and anterior nuclei could not be quantified because their dorso-medial portion was damaged in several samples. The borders of the TRN were identified according to specific landmarks, such as the internal capsule laterally and the subthalamic nucleus ventromedially. Each traced region was systematically scanned through the full *x*-, *y*-, and *z*-axes to count each WFA-labeled PNN over complete sets of serial sections (6--10 sections) representing the whole extent of the amygdala from each subject (section interval 1040 μm). Outcome measures were plotted by time of death (TOD) for each subject to analyze potential diurnal fluctuations using approaches reported previously in postmortem studies ([@B72]; [@B30]; [@B118]; [@B49]; [@B51]; [@B58]; [@B94]; [@B82]).

Statistical analysis {#s3G}
--------------------

Differences between groups relative to the main outcome measures were assessed for statistical significance using stepwise linear regression (ANCOVA). Logarithmic transformation was uniformly applied to all human data values because data were not normally distributed. Statistical analyses were performed using JMP PRO v14 (SAS Institute Inc.). Average daily wheel-running activity was included as a covariate for all mouse studies. TOD was obtained from the death certificate for each subject and tested for potential effects on outcome measures. TOD was also used to divide subjects into subjective day (s-Day TOD, 6 A.M. to 5:59 P.M.) and subjective night (s-Night, 6 P.M. to 5:59 A.M.) groups on the basis of previous literature indicating diurnal fluctuations in the amygdala of humans and mice ([@B9]; [@B4]; [@B92]). Effects of TOD on outcome measures were analyzed using two steps: (1) subjects were divided into s-Day versus s-Night groups for comparisons using stepwise linear regression analysis; and (2) we used quartic regression analysis on plots of **N~t~**of WFA-labeled PNNs by TOD for each group according to methods used to detect similar relationships in postmortem studies ([@B118]; [@B49]; [@B58]). Quartic regression models were used as described previously ([@B82]) to fit expression patterns reported in the mouse and human amygdala consisting of two peaks and two troughs ([@B1]; [@B82]).

Numerical densities (mouse samples) {#s3H}
-----------------------------------

Numerical densities were calculated as **N~d~ = ∑N/∑V** where N = sum of all PNNs counted in each region for each animal, and **V** is the volume of each region per animal, calculated as **V = ∑a • z**, where z is the thickness of each section (30 μm) and a is area in μm^2^. Rhythmic relationships of PNNs and cathepsin-S in mice were analyzed by plotting means and SD per each time point across the 24-h cycle, as conducted in previous studies ([@B55]; [@B96]; [@B44]).

Numerical densities and total numbers estimates (human samples) {#s3I}
---------------------------------------------------------------

Total number (**N~t~**) of WFA-labeled PNNs was calculated as **N~t~ = i • Σn**, where Σ*n* = sum of the cells counted in each subject, and **i** is the section interval (i.e., number of serial sections between each section and the next within each compartment = 26) as described previously ([@B10]). Numerical densities were calculated as **N~d~** = **∑N/∑V**, where **V** is the volume of each amygdala nucleus or the TRN, calculated as **V** = **z • ssf • Σ a**, where ***z*** is the thickness of the section (40 μm), ***ssf*** is the section sampling fraction (1/26; i.e., number of serial sections between each section within a compartment), and **a** is the area of the region of interest.

Animals {#s3J}
-------

Adult male wild-type C57/BL6 mice housed in individual wheel-running cages in a 12/12 h light/dark (LD) cycle were used to examine diurnal rhythms of PNN composition. Three male C57/BL6 mice were killed every 4 h across the 24-h cycle at ZT0, ZT4, ZT8, ZT12, ZT16, and ZT20. A separate set of adult male C57/BL6 mice were used to test for circadian rhythms of PNN composition. Mice were housed in a 12/12 LD cycles for four weeks, followed by three full 24-h cycles in constant darkness, then killed every 4 h at circadian time (CT)0, CT4, CT8, CT12, CT16, and CT20, three mice per time point. Wheel-running actigraphs were used to determine individual CT times for killing animals housed in constant darkness. Activity onset over three 24-h cycles was used to predict CT time in the fourth cycle during which animals were killed. All animals in the constant darkness study were killed under dim red light conditions. Circadian rhythm of each mouse was monitored with ClockLab (Actimetrics) using wheel-running activity data. Mice were killed using cervical dislocation in the light or in the dark using a dim red light, depending on lighting conditions at time of killing. Mice were perfused intracardially with 4% PFA, and brains were stored in 0.1 [m]{.smallcaps} PB with 0.1% Na azide and 30% sucrose. Brains were then sliced into serial 30-μm brain sections on an American Optical freezing microtome. The housing and treatment of experimental animals were approved by the University of Mississippi Medical Center Institutional Animal Care and Use Committee and followed guidelines set by the National Institutes of Health.

Human subjects and tissue processing {#s3K}
------------------------------------

Tissue blocks containing the whole amygdala or thalamus from 15 donors were obtained from the Harvard Brain Tissue Resource Center, McLean Hospital, Belmont, MA ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Diagnoses were made by two psychiatrists on the basis of retrospective review of medical records and extensive questionnaires concerning social and medical history provided by family members. A neuropathologist examined several regions from each brain for a neuropathology report. The cohort for this study did not include subjects with evidence for gross and/or macroscopic brain changes, or clinical history consistent with cerebrovascular accident or other neurologic disorders. Subjects with Braak and Braak Stages III or higher were not included. Subjects had no significant history of psychiatric illness, or substance dependence, other than nicotine and alcohol, within 10 years from death.

###### 

TRN sample demographic and descriptive characteristics

  Case              Age           Sex     Cause of death        Brain weight (g)   PMI (hrs)    Hemisphere   TOD
  ----------------- ------------- ------- --------------------- ------------------ ------------ ------------ -------
  S05735            74            F       Cancer (C)            1145               12.2         L            14.00
  S16022            68            F       Cardiac arrest (A)    1330               14.75        R            09.30
  S13845            37            M       Electrocution (A)     1460               18.75        R            21.00
  S14247            72            M       Cardiac arrest (A)    1560               28.2         R            07.35
  S10160            85            M       Cancer (C)            1225               20.3         L            05.30
  S18228            78            F       Cancer (C)            1100               23.9         L            05.00
  S07594            95            F       Unknown               1350               7.1          R            14.50
  S06087            69            F       Unknown               1280               25.2         R            10.16
  S07749            61            M       Unknown               1280               10.1         R            12.30
  S07429            68            F       Unknown               1230               24.8         R            19.45
  S14342            70            F       Cardiac arrest (A)    1245               18.0         R            07.29
  S08987            53            F       Cancer (C)            1330               24.0         R            08.32
  S11774            74            M       Cardiac arrest (A)    1490               15.81        R            08.41
  S03774            70            M       Aortic aneurysm (A)   1400               17.3         R            20.46
  S17165            58            F       COPD (C)              1345               17.8         R            00.35
  Total/mean ± SD   68.8 ± 13.5   9F 6M                         1318.0 ± 125.1     18.5 ± 6.0   3L 12R       

###### 

Amygdala sample demographic and descriptive characteristics

  Case              Age           Sex     Cause of death        Brain weight (g)   PMI (hrs)    Hemisphere   TOD
  ----------------- ------------- ------- --------------------- ------------------ ------------ ------------ -------
  S90122            70            M       Cardiac arrest (A)    1360               23.2         L            12.17
  S23073            52            M       Cardiac arrest (A)    \-                 32.1         L            03.07
  S12827            71            M       Cardiac arrest (A)    1580               24.0         L            10.10
  S13845            37            M       Electrocution (A)     1460               18.75        R            21.00
  S07340            65            M       Cardiac arrest (A)    1240               17.3         L            06.45
  S08987            53            F       Cancer (C)            1330               24.0         R            08.32
  S30877            62            M       Cardiac arrest (A)    1300               29.2         L            21.18
  S03774            70            M       Aortic aneurysm (A)   1400               17.3         R            20.46
  S17232            58            M       COPD (C)              1066               19.3         R            16.08
  S14247            72            M       Cardiac arrest (A)    1560               28.2         R            07.35
  S05735            74            F       Cancer (C)            1145               12.2         L            14.00
  S16022            68            F       Cardiac arrest (A)    1330               14.75        R            09.30
  S10160            85            M       Cancer (C)            1225               20.3         L            05.30
  S18228            78            F       Cancer (C)            1100               23.9         L            05.00
  Total/mean ± SD   65.4 ± 12.2   5F 9M                         1315.0 ± 161.3     21.8 ± 5.7   8L 6R        

A, acute death, no prolonged agonal period; C, chronic, prolonged agonal period; COPD, chronic obstructive pulmonary disease; PMI, postmortem time interval.

Tissue blocks were dissected from fresh brains and postfixed in 0.1 [m]{.smallcaps} PB containing 4% paraformaldehyde and 0.1 [m]{.smallcaps} Na azide at 4°C for three weeks, cryoprotected at 4°C for three weeks (30% glycerol, 30% ethylene glycol, and 0.1% Na azide in 0.1 [m]{.smallcaps} PB), embedded in agar, and presliced in 2-mm coronal slabs using an Antithetic Tissue Slicer (Stereological Research Lab.). Each slab was exhaustively sectioned using a freezing microtome (American Optical 860). Sections were stored in cryoprotectant at −20°C. Using systematic random sampling criteria, sections through the amygdala were serially distributed in 26 compartments (40-μm-thick sections; 6--10 sections/compartment; 1.04-mm section separation within each compartment). All sections within one compartment/subject were selected for histochemistry (i.e., WFA), thus respecting the "equal opportunity" rule ([@B22]; [@B43]).

Sleep deprivation {#s3L}
-----------------

Adult male wild-type C57/Bl6 mice housed in 12/12 LD cycle were used for sleep deprivation experiments. Mice were either sleep deprived using gentle handling for 5 h from lights on (7 A.M.) to 12 P.M. (*n* = 12) or handled during the dark phase for 5 h the night before (controls; *n* = 12), to control for potential confounding effects of handling on the outcome measures. Mice were killed immediately following 5 h of sleep deprivation, and control mice were killed at the same time (ZT5: 12 P.M.). Mice were perfused intracardially with 4% PFA, and brains were stored in 0.1 [m]{.smallcaps} PB with 0.1% Na azide and 30% sucrose. Brains were then sliced into serial 30-μm brain sections on an American Optical freezing microtome. WFA labeling was used to quantify PNNs in the habenula, prefrontal cortex, amygdala, thalamus, and hippocampus using stereology-based sampling methods.

Mouse auditory fear conditioning {#s3M}
--------------------------------

Auditory contextual fear conditioning was conducted as described previously ([@B39]). Mice were placed in a fear conditioning box at ZT0 (7 A.M.; 64 cm wide, 73 cm deep, and 68 cm high; Med Associates) placed in a larger, sound-attenuating chamber. Precisely four mice will be placed in four boxes chamber (one mouse for each box) at the same time for experimental comparison. Mice remained in the chamber for 3 min before delivery of four tones, each of 10-s duration (85 dB, 10 kHz). Each tone was followed by a footshock lasting 2 s (0.8-mA amplitude) pairings were administered (60- to 200-s variable inter tone interval; total time mice spent inside the chamber was 15--18 min). After the test, the mice were placed back into normal housing (four control mice, or sleep deprived for 5 h before being placed back into normal housing (four mice).

Mice were returned to the context on the second day for an extinction session (10-min total inside the chamber with no shock and tone) then placed back in their cages. Mice were placed in a novel context on the third day at 7 A.M. for auditory fear extinction inside the chamber for a total time of 5 min (3 min pretone; 60 s, 85 dB, 10 kHz tone; 60 s posttone period). Low freezing before the onset of tone presentation indicated that animals did not generalize fear to the novel context, and also enabled us to conclude that freezing observed during the tone was evoked specifically by the tone. Freezing behavior was defined as periods of at least 1 s with the complete absence of movement except breathing; it was measured with manual scoring. The percent of time spent freezing during intervals of interest was quantified, and these results were analyzed using ANOVA. *Post hoc* Fisher's PLSD tests were performed after a significant omnibus *F* ratio.

Cathepsin-S PNN digestion {#s3N}
-------------------------

Free floating mouse brain sections were incubated with 300 ng of active human cathepsin-S (SRP0292, Sigma-Aldrich), in activation buffer containing 1.8 m[m]{.smallcaps} DTT, 1.8 m[m]{.smallcaps} EDTA, 1% BSA, 12 m[m]{.smallcaps} citric acid, and 43 m[m]{.smallcaps} Na~2~HPO~4~ at 37°C for either 3 h or 24 h. Control sections were incubated in activation buffer (1.8 m[m]{.smallcaps} DTT, 1.8 m[m]{.smallcaps} EDTA, 1% BSA, 12 m[m]{.smallcaps} citric acid, and 43 m[m]{.smallcaps} Na~2~HPO~4~) at 37°C in parallel. Following cathepsin-S incubation, sections were labeled with WFA and WFA+ PNNs were quantified in the hippocampus as described above.

Results {#s4}
=======

We use the chronobiology term "circadian" to refer to rhythms observed in constant darkness, regulated by endogenous circadian processes in the absence of environmental signals that can entrain rhythms such as light-dark cycles. We use the term "diurnal" to refer to rhythms observed in light-dark cycles, which may reflect immediate responses to environmental cycles rather than true circadian rhythms.

Diurnal rhythms of PNNs in the mouse brain {#s4A}
------------------------------------------

In a cohort of adult male C57/BL6 mice, housed in a 12/12 LD cycle, we observed diurnal rhythms in the density of WFA+ PNNs in the hippocampus, amygdala, prefrontal cortex, habenula, and TRN ([Figs. 1](#F1){ref-type="fig"}-[5](#F5){ref-type="fig"}). WFA+ PNN rhythms in the hippocampal sectors displayed consistent peaks at ZT20, and troughs at ZT6 across hippocampal sectors ([Fig. 1](#F1){ref-type="fig"}). WFA+ PNN density rhythms in the amygdala were similar to hippocampal rhythms, with peaks at ZT20 and troughs at ZT8 across amygdala nuclei ([Fig. 2](#F2){ref-type="fig"}). Similar relationships were observed in the prefrontal cortex, with WFA+ PNN densities displaying peaks at approximately ZT0 and troughs at ZT8 ([Fig. 3](#F3){ref-type="fig"}). WFA+ PNN density rhythms in the habenula ([Fig. 4](#F4){ref-type="fig"}) and TRN ([Fig. 5](#F5){ref-type="fig"}) also displayed consistent diurnal rhythms, with peaks at approximately ZT20 and troughs at ZT8. ANCOVA models testing the main effect of ZT time and the effect of average daily amount of wheel running activity showed significant effects of ZT time on WFA+ PNN densities in all regions examined ([Table 3](#T3){ref-type="table"}). In comparison, average daily amount of wheel-running activity showed a significant effect on densities of WFA+ PNNs in only the central amygdala and TRN ([Table 3](#T3){ref-type="table"}).

###### 

Summary table of ZT time and average daily running activity effects on WFA+ PNN and CatS-IR cell densities

                              ZT time*F* ratio   ZT time*p* value   Avg daily wheel runningactivity *F* ratio   Avg daily wheel runningactivity *p* value
  --------------------------- ------------------ ------------------ ------------------------------------------- -------------------------------------------
  CA1 PNNs                    **12.51**          **0.004**          0.01                                        0.92
  CA2/3 PNNs                  **20.21**          **\<0.0001**       4.07                                        0.07
  CA4 PNNs                    **26.55**          **\<0.0001**       23.71                                       0.12
  DG PNNs                     **7.38**           **0.003**          0.02                                        0.91
  Lateral amygdala PNNs       **9.16**           **0.001**          0.02                                        0.98
  Basolateral amygdala PNNs   **10.81**          **0.0007**         1.72                                        0.22
  Central amygdala PNNs       **48.66**          **\<0.0001**       **18.15**                                   **0.002**
  TRN PNNs                    **4.69**           **0.02**           **5.71**                                    **0.03**
  Lateral habenula PNNs       **10.25**          **0.0009**         0.88                                        0.37
  Medial habenula PNNs        **5.31**           **0.01**           0.07                                        0.78
  IL superficial PNNs         **14.72**          **0.001**          0.03                                        0.96
  IL deep PNNs                **10.94**          **0.003**          0.88                                        0.38
  PL superficial PNNs         **28.16**          **0.0002**         2.51                                        0.16
  PL deep PNNs                **31.77**          **\<0.001**        0.94                                        0.37
  CA1 CatS                    **9.48**           **0.008**          2.29                                        0.18
  CA2/3 CatS                  **5.88**           **0.02**           1.12                                        0.33
  CA4 CatS                    **6.79**           **0.01**           3.01                                        0.13
  DG CatS                     **54.10**          **\<0.0001**       5.59                                        0.06
  Lateral amygdala CatS       **6.01**           **0.02**           0.22                                        0.65
  Basolateral amygdala CatS   **26.25**          **0.0002**         3.95                                        0.09
  Central amygdala CatS       **14.21**          **0.001**          0.02                                        0.88
  IL superficial CatS         **8.20**           **0.05**           0.17                                        0.71
  IL deep CatS                **7.67**           **0.04**           0.50                                        0.52
  PL superficial CatS         **28.21**          **0.009**          0.18                                        0.70
  PL deep CatS                **93.77**          **0.002**          0.009                                       0.92

Values represent *F* ratios and *p* values derived from ANCOVA models testing effects of ZT time and average daily wheel-running activity on WFA+ PNN densities and cathepsin-S-IR cell densities. Statistically significant differences are indicated in bold = *p* \< 0.05.

![Diurnal rhythms of PNNs in the mouse hippocampus. Analysis of WFA+ PNNs across the 24-h cycle in male mice housed in a 12/12 h LD cycle revealed a diurnal rhythm of WFA+ PNNs in hippocampal sectors CA1 (***A***) CA2/3 (***B***), CA4 (***C***), and the DG (***D***) with peaks at ∼ZT20 and troughs at ∼ZT8. Error bars represent SD. Representative low-magnification images of WFA labeling in the mouse hippocampus at ZT8 (***E***) and ZT20 (***F***).](SN-ENUJ200189F001){#F1}

![Diurnal rhythms of PNNs in the mouse amygdala. Diurnal rhythms of WFA+ PNNs were observed in the lateral amygdala (***A***) basal amygdala (***B***), and central amygdala (***C***) with peaks at ∼ZT20 and troughs at ∼ZT8. Error bars represent SD. Representative low-magnification images of WFA labeling in the mouse amygdala at ZT8 (***D***) and ZT20 (***E***).](SN-ENUJ200189F002){#F2}

![Diurnal rhythms of PNNs in the mouse prefrontal cortex. Diurnal rhythms of WFA+ PNNs were observed in the infralimbic superficial (***A***) prelimbic superficial (***B***), infralimbic deep (***C***), and prelimbic deep (***D***) layers of the mouse, with peaks at ∼ZT0 and troughs at ∼ZT8. Error bars represent SD. Representative low-magnification images of WFA labeling in the mouse prefrontal cortex at ZT8 (***E***) and ZT20 (***F***).](SN-ENUJ200189F003){#F3}

![Diurnal rhythms of PNNs in the mouse habenula. Analysis of WFA+ PNNs across the 24-h cycle in male mice housed in a 12/12 h LD cycle revealed a diurnal rhythm of WFA+ PNNs in the lateral habenula (***A***) and medial habenula (***B***), with a peak at ∼ZT0 and trough at ∼ZT8 for the lateral habenula, and a peak at ∼ZT16 and trough at ∼ZT8 for the medial habenula. Error bars represent SD. Representative low-magnification images of WFA labeling in the mouse habenula at ZT8 (***C***) and ZT20 (***D***).](SN-ENUJ200189F004){#F4}

![Diurnal rhythms of PNNs in the mouse TRN. Analysis of WFA+ PNNs across the 24-h cycle in male mice housed in a 12/12 h LD cycle revealed a diurnal rhythm of WFA+ PNNs in the TRN (***A***) with a peak at ∼ZT20 and a trough at ∼ZT8. Error bars represent SD. Representative low-magnification images of WFA labeling in the mouse TRN at ZT8 (***B***) and ZT20 (***C***).](SN-ENUJ200189F005){#F5}

Circadian rhythms of PNNs in the mouse brain {#s4B}
--------------------------------------------

These studies were designed to assess whether diurnal rhythms in mice reflect a true circadian rhythm, and to confirm the existence of PNN density rhythms in a separate strain of mice. We used adult male C57/Bl6 mice housed in a 12/12 LD cycle and then placed into constant darkness for three full 24-h cycles to quantify WFA+ PNN rhythms in free-running circadian conditions. In mice kept in constant darkness, numerical density of WFA+ PNNs displayed circadian rhythms in all regions identical to diurnal rhythms described above, with consistent peaks at approximately CT20 and troughs at approximately CT8 across regions ([Fig. 6](#F6){ref-type="fig"}).

![Circadian rhythms of PNNs in the mouse brain. Circadian rhythms in the density of WFA+ PNNs were observed in mice housed in constant darkness. In the hippocampus, these rhythms were similar to the diurnal rhythms observed in the CA regions and the DG (***A--D***); circadian rhythms in the density of WFA+ PNNs in the mouse prefrontal cortex also paralleled the observed diurnal rhythms in these regions, with peaks at ∼CT0 and troughs at ∼CT8 (***E--H***), with the exception of the deep layers of the IL cortex, which showed a peak at ∼CT20 and trough at CT8 (***F***). Circadian rhythms of WFA+ PNN densities were also observed in the lateral, basal, and central amygdala nuclei in constant darkness, with a peak at ∼CT16 and a trough at ∼CT6 (***I--K***). Circadian rhythms of WFA+ PNN densities in the lateral and medial habenula and TRN paralleled diurnal PNN rhythms in these regions (***L--N***). Error bars represent SDs.](SN-ENUJ200189F006){#F6}

Sleep deprivation prevents the decrease of PNNs during the day in the mouse hippocampus {#s4C}
---------------------------------------------------------------------------------------

Sleep deprivation by gentle handling has been previously shown to prevent synaptic modification that occurs in the hippocampus during sleep in rodents ([@B46]; [@B91]). Here, we use the same approach to test the hypothesis that sleep deprivation prevents the decrease of WFA+ PNN densities in the mouse hippocampus. Mice that were sleep deprived for 5 h (ZT0--ZT5) starting from the beginning of the light cycle had significantly higher numerical density of WFA+ PNNs in the dentate gyrus (*p* = 0.01) and sectors CA4 (*p* = 0.01), CA3/2 (*p* = 0.01), and CA1 (*p* = 0.001; [Fig. 7*B-D*](#F7){ref-type="fig"}). Similar differences in WFA+ PNN densities were observed in the amygdala, habenula, and prefrontal cortex ([Fig. 7*E-G*](#F7){ref-type="fig"}). In a set of animals that underwent auditory fear conditioning, 5 h of sleep deprivation significantly enhanced fear memory extinction ([Fig. 7*A*](#F7){ref-type="fig"}).

![Sleep deprivation prevents PNN decreases. Five hours of sleep deprivation, from lights on (7 A.M.) to 12 P.M. following auditory fear conditioning, resulted in rapid extinction of fear memory (***A***), along with significantly higher numerical density of WFA+ PNNs in the hippocampus (***B***). Representative photomicrographs of the hippocampus labeled with WFA from a control mouse (***C***) and a sleep-deprived mouse (***D***). Scale bar = 1000 μm. Similar increases in densities of WFA+ PNNs in SD mice were also observed in the amygdala (***E***), habenula (***F***), and prefrontal cortex (***G***). Error bars represent 95% confidence intervals.](SN-ENUJ200189F007){#F7}

Association of cathepsin-S microglia with diurnal PNN rhythms {#s4D}
-------------------------------------------------------------

Cathepsin-S has been reported to be rhythmically expressed in the mouse prefrontal cortex and associated with diurnal rhythms in dendritic spines and electrophysiological properties of prefrontal cortex neurons ([@B48]). As a first step in testing whether cathepsin-S may contribute to circadian modification of PNN integrity, we tested the hypothesis that its expression in microglia may vary according to a diurnal rhythm, antiphase to WFA+ PNN rhythms. We observed a diurnal rhythms of cathepsin-S-IR microglia densities in the mouse hippocampus, antiphase to the rhythms of WFA+ PNNs in this region ([Fig. 8](#F8){ref-type="fig"}), with peaks at approximately ZT6 and troughs at ZT0. Similar diurnal cathepsin-S rhythms were observed in the amygdala and prefrontal cortex ([Fig. 9](#F9){ref-type="fig"}). No significant effects of average daily wheel-running activity on cathepsin-S-IR cell densities were observed ([Table 3](#T3){ref-type="table"}). Finally, to confirm that cathepsin-S degrades PNNs, we incubated mouse sections in active cathepsin-S (3 and 24 h). Our results show an incubation time-dependent decrease of WFA+ PNN labeling, with a significant 54.5% decrease after 3 h (*p* \< 0.02) and a complete elimination after 24 h (*p* \< 0.0001; [Fig. 10*A-F*](#F10){ref-type="fig"}). Dual immunohistochemistry confirmed that virtually all (88.12--92.95%) of cathepsin-S-IR cells in the mouse hippocampus, infralimbic and prelimbic cortex, amygdala, habenula, and TRN correspond to IBA1-positive microglia ([Fig. 10*G-N*](#F10){ref-type="fig"}).

![Cathepsin-S diurnal rhythms in the mouse hippocampus. Diurnal rhythms in densities of cathepsin-S-IR cells were observed in CA1 (***A***), CA2/3 (***B***), CA4 (***C***), and the DG (***D***) in mice, with expression peaking during the middle of the light cycle, when WFA+ PNN numbers are low in these regions, and decreasing during the dark cycle, when WFA+ PNN densities are high. Error bars represent SD. Representative photomicrographs of the hippocampus labeled with cathepsin-S at ZT8 (***E***) and ZT20 (***F***).](SN-ENUJ200189F008){#F8}

![Cathepsin-S diurnal rhythms in the mouse amygdala and prefrontal cortex. Diurnal rhythms in densities of cathepsin-S-IR cells were observed in the lateral amygdala (***A***), basal amygdala (***B***), and central amygdala (***C***), with expression peaking during the middle of the light cycle, when WFA+ PNN numbers are low in these regions, and decreasing during the dark cycle, when WFA+ PNN densities are high. Similar diurnal rhythms were also observed in the infralimbic cortex superficial layers (***D***), prelimbic cortex superficial layers (***E***), infralimbic cortex deep layers (***F***), and prelimbic cortex deep layers (***G***). Error bars represent SD.](SN-ENUJ200189F009){#F9}

![Cathepsin-S is expressed in microglia and eliminates PNN labeling. Significant reduction in WFA+ PNNs is observed after 3 h of cathepsin-S incubation (***A--C***) and a complete absence of PNN labeling after 24 h (***D--F***). Error bars represent 95% confidence interval. Scale bars = 1000 μm. Dual fluorescence immunohistochemistry demonstrated that the vast majority of cathepsin-S-IR cells in the mouse hippocampus co-express the microglial marker IBA1 (***G--N***). Scale bar = 50 μm.](SN-ENUJ200189F010){#F10}

Diurnal rhythms of PNNs in the human amygdala and TRN {#s4E}
-----------------------------------------------------

For these studies, we used TOD for each subject as a proxy for diurnal rhythms (ZT; see Discussion) to test the hypothesis that WFA+ PNN numbers vary in a diurnal manner in the human amygdala and TRN. We observed differences in WFA+ PNN numbers in subjects with a TOD during the day in comparison to subjects with a TOD during the night in the human amygdala ([Fig. 11*A-D*](#F11){ref-type="fig"}). Quartic regression analysis revealed a diurnal rhythm of WFA+ PNNs Nt in the human amygdala ([Fig. 11*D*](#F11){ref-type="fig"}), with peaks at noon and midnight, and troughs at 4 A.M. and 8 P.M. In contrast, we observed day/night differences in WFA+ PNN numbers in the human TRN that are opposite to the human amygdala, with higher numbers of PNNs at night and lower numbers during the day ([Fig. 11*E-H*](#F11){ref-type="fig"}). Quartic regression plots revealed peaks of WFA+ PNN numbers in the TRN at night during 4 A.M. and 8 P.M., and the lowest numbers at 12 P.M. and midnight ([Fig. 11*H*](#F11){ref-type="fig"}).

![Diurnal rhythms of PNNs in the human brain. WFA+ PNN numbers vary with TOD in the human brain. Photomicrograph depicting PNN labeling by WFA lectin in the human amygdala during the day (***A***) and at night (***B***). WFA+ PNNs displayed a significant day/night difference in the human amygdala (***C***), with peaks PNN numbers at noon and midnight, and troughs at 4 A.M. and 8 P.M. ***D***, Photomicrograph depicting PNN labeling in the human TRN during the day (***E***) and at night (***F***). Significant day/night differences were observed in total numbers of WFA+ PNNs in the TRN (***G***). Quartic regression plots revealed a dual peak rhythm in the TRN that is antiphase to the rhythm observed in the amygdala (***H***). Error bars represent 95% confidence intervals.](SN-ENUJ200189F011){#F11}

Discussion {#s5}
==========

We present, to our knowledge for the first time, evidence that WFA+ PNN vary according to diurnal rhythms in the human brain and to diurnal and circadian rhythms in the rodent brain. Our data add to a growing number of studies demonstrating that PNNs are dynamic structures, responding to the environment and potentially contributing to memory consolidation during sleep ([@B7]; [@B15]; [@B8]; [@B28]; [@B102]), We show that numbers of WFA+ PNN follow diurnal rhythms in several brain regions in mouse and in human. Importantly, we show that WFA+ PNN rhythmicity occurs in mice kept in constant darkness, supporting the claim that these changes reflect circadian rhythms rather than a response to light-dark cycles ([Fig. 6](#F6){ref-type="fig"}). Our results also provide evidence for a role of the microglia-derived matrix protease cathepsin-S, known to contribute to synaptic plasticity ([@B48]). We show a diurnal rhythm of cathepsin-S expression in microglia, opposite to the observed PNN rhythms, and demonstrate that cathepsin-S eliminates WFA+ PNN labeling. Taken together, these results support the hypothesis that cathepsin-S may represent one of the endogenous proteases contributing to WFA+ PNN rhythms. PNN rhythms in the mouse hippocampus coincide with reported rhythms in LTP, suggesting that WFA+ PNNs decrease during sleep, when lower levels of LTP were reported to occur ([@B20]), and increase during wakefulness when higher levels of LTP occur as animals encode new memories ([@B50]; [Fig. 6](#F6){ref-type="fig"}). We suggest that diurnal rhythms of WFA+ PNNs in the regions examined may have broad implications for emotional memory processing and psychiatric disorders.

Technical considerations {#s5A}
------------------------

### Interpretation of WFA+ PNN rhythms {#s5A1}

PNNs are highly complex structures formed by several glycoproteins and proteoglycans, link proteins and hyaluronan ([@B61]; [@B71]). WFA detects a specific sulfation motif on *N*-acetylgalactosamine at the terminal ends of CS chains ([@B19]; [@B71]). CS chains can be modified by addition of sulfation groups at the two, four, or six positions along the chains, allowing for highly complex and dynamic modification ([@B19]; [@B61]; [@B71]; [@B81]). Furthermore, CS chains can be cleaved at varying points along the chain by several matrix proteases ([@B74]; [@B87]; [@B81]). Together, these considerations suggest that it is unlikely that the complex PNN structure may be entirely degraded and rebuilt on a 24-h cycle. We propose that the diurnal and circadian WFA+ PNN rhythms we observed may reflect modifications of the biochemical characteristics of these structures, perhaps impacting the CS chain sulfation pattern detected by WFA. It is important to emphasize that growing and compelling evidence shows that PNN and ECM functions are dictated by dynamic posttranslational modifications of their components mediated by matrix proteases ([@B77]; [@B56]; [@B115]). Notably, these modifications determine whether effects of ECM components on synaptic plasticity are inhibitory or permissive ([@B71]; [@B35]; [@B117]). Our data showing cathepsin-S rhythms antiphase to PNN rhythms, and the ability of cathepsin-S to eliminate WFA+ PNN labeling, support this interpretation and represent the first step in examining this process. However, a significant limitation is that our current data show associations but do not demonstrate mechanistic effects of cathepsin-S expression rhythms on PNN rhythms. Our data showing diurnal rhythms of cathepsin-S expression represents the first step in testing a broad range of proteases from several cell types. Circadian regulation of PNNs is likely to consist of a complex molecular signaling system involving multiple proteases and ECM molecules, encompassing several cell types. Future studies focused on circadian expression of specific PNN components, matrix proteases and sulfotransferases will provide insight into the mechanisms underlying circadian PNN modification and direct effects on memory processing.

### TOD in human postmortem subjects as a proxy for diurnal rhythms (ZT) {#s5A2}

Human postmortem studies have successfully used TOD as a proxy for diurnal rhythms (approximate ZT), to study diurnal rhythms of gene and protein expression in human brain. An obvious limitation is that TOD represents a single measure per subject at a specific time point, rather than repeated measures across time. However, several human studies demonstrated predicted rhythmic expression of clock genes in several brain regions, and of SST in the amygdala ([@B58]; [@B17]; [@B21]; [@B82]). Importantly, rhythmic patterns, such as peak phase relationships between clock molecules, demonstrated in human were consistent with those reported in rodents, including staggered phase relationship between Per1, Per2, and Per3 genes ([@B55]; [@B89]; [@B1]; [@B58]). Molecular rhythms reported in the human cortex have been independently replicated, providing further support for the validity of this approach ([@B58]; [@B21]). The WFA+ PNN rhythms observed in the amygdala nocturnal mice ([Figs. 1](#F1){ref-type="fig"}, [6](#F6){ref-type="fig"}) are antiphase to the PNN rhythms observed in diurnal human subjects in the same region ([Fig. 11](#F11){ref-type="fig"}), providing further support for the approach of using TOD to analyze rhythmic relationships in human postmortem samples.

Implications for synaptic plasticity and memory consolidation {#s5B}
-------------------------------------------------------------

Several hypotheses have been put forth to link wake/sleep cycles to synaptic mechanisms underlying memory consolidation. For instance, studies from Tononi and Cirelli support the synaptic homeostasis hypothesis of sleep ([@B109], [@B110]). Briefly, neurons form and strengthen many new synapses during wakefulness, as organisms interact with their environment and encode new memories. During sleep, when the active encoding process is offline, synapses are downscaled, to enhance the signal-to-noise ratio, thus improving memory function ([@B109], [@B110]). Consistent with this hypothesis, decreases of dendritic spines and synapses during sleep have been reported in sensory and motor cortical regions ([@B66]; [@B27]). An alternative theory, suggested by Rasch and Born, postulates that memories are reorganized during slow wave sleep in a process called systemic consolidation ([@B90]). During systemic consolidation, memory representations are reactivated and transferred from short-term storage sites, such as the hippocampus, into long-term storage in neocortical areas where they are integrated into existing schemas ([@B90]). Memories are then strengthened in these long-term storage areas during REM sleep, in a process called synaptic consolidation, while the short-term storage memories are removed via synaptic pruning ([@B90]).

We speculate that diurnal molecular modifications of PNNs may contribute to memory formation and consolidation mechanisms during the wake/sleep cycle, favoring activity-driven synaptogenesis and synaptic refinement, respectively. For instance, our results on the effects of 5-h sleep deprivation on WFA+ PNNs in the mouse hippocampus are consistent with reports that 5 h of sleep deprivation prevents changes in dendritic spine densities in the hippocampus occurring during sleep ([@B46]; [@B91]; [@B104]; [@B40]). PNN rhythms observed in our study may reflect ongoing systemic and synaptic consolidation during sleep proposed by Rasch and Born ([@B90]). For instance, WFA+ PNNs changes in mice the hippocampus are more active during wakefulness, as suggested by enhanced LTP in this region during the night ([@B20]). Regional differences in PNN rhythms may also reflect phase differences in molecular clock rhythms of these regions. Region specific rhythms in the clock protein Per2 have been described previously in rodents and humans ([@B55]; [@B58]; [@B44]; [@B21]).

Recent evidence shows that cathepsin-S deletion in knock-out mice contributes to failure to downscale synapses during sleep ([@B48]). In these mice, reduced EEG δ wave power and failure to reduce amplitude and frequency of action potentials and to reduce dendritic spines during sleep supports a role for cathepsin-S in downscaling synaptic strength during sleep ([@B48]). Our results show that rhythms of cathepsin-S expression are antiphase with respect to WFA+ PNNs rhythms, i.e., high cathepsin-S expression is associated with low WFA+ PNN numbers, and that cathepsin-S reduces WFA+ PNN labeling. Together, these findings suggest that increased cathepsin-S during sleep may represent one of several molecules that contribute to modifying PNN composition. In turn, such modifications may contribute to synaptic downscaling and remodeling during memory consolidation ([Fig. 12](#F12){ref-type="fig"}). This hypothesis is supported by evidence for the involvement of the microglial circadian molecular clock in the regulation of microglial morphology, immune response, and synaptic regulation ([@B47],[@B48]; [@B34]). Our results suggest an additional circadian role for microglia in synaptic regulation, through PNN modification potentially modulating memory consolidation processes.

![Microglial expression of cathepsin-S may modify PNNs to allow for memory consolidation during sleep. In the mouse hippocampal sector CA1, diurnal rhythms in the numerical density of WFA+ PNNs decreases during the day as mice sleep, reaching the lowest density in WFA+ PNN numbers between ZT4--ZT10 (green curved line). This coincides with the peak expression of cathepsin-S (red curved line) and the reported daytime decrease in LTP (blue circles; from [@B20]). In comparison, the numerical density of WFA+ PNNs peaks during the dark at ∼ZT20 during the active period for nocturnal mice, coinciding with the low point of cathepsin-S immunoreactivity in this region as well as the reported increase in LTP at night in mice (pink circles; from [@B20]). These results suggest that cathepsin-S modifies PNN composition, coinciding with decreased TLP during sleep, to allow for memory consolidation, and PNN composition is restored during the active wake periods to allow for optimal encoding of novel information.](SN-ENUJ200189F012){#F12}

Circadian rhythms in PNN composition may also be regulated by proteases and CSPG production from several cell types including astrocytes and neurons, which produce many of the core PNN components as well as endogenous proteases known to modify PNNs ([@B77]; [@B70]; [@B13]). Furthermore, although our evidence suggests that circadian rhythms in PNN composition may contribute to synaptic regulation during sleep, we do not demonstrate a mechanistic effect on synaptic regulation or memory consolidation. PNN circadian rhythms may be involved in other processes such as resolution of oxidative stress during sleep. Several studies suggest that sleep deprivation contributes to increased oxidative stress in in the brain ([@B99]; [@B88]; [@B2]; [@B45]), and PNNs are critically involved in protecting fast-firing neurons from oxidative stress ([@B18]). Thus, rhythms in PNN composition may reflect periods of reduced neuronal activity and resolution of oxidative stress during sleep. A recent study reporting increased oxidative stress in parvalbumin (PVB) neurons together with increased WFA labeling of PNNs following sleep deprivation supports this hypothesis ([@B45]).

Implications for psychiatric disorders {#s5C}
--------------------------------------

In the present study, we focused on brain regions involved in emotional memory processing and implicated in psychiatric disorders ([@B111]; [@B93]; [@B57]; [@B62]; [@B67]; [@B69]; [@B82]; [@B114]). Diurnal rhythms of PNNs in human subjects have broad implications for psychiatric disorders. PNN deficits have been reported by several groups in the amygdala, entorhinal cortex, hippocampus, prefrontal cortex, and TRN in schizophrenia and bipolar disorder ([@B79], [@B80], [@B81]; [@B67]; [@B31]; [@B105]). Disruption of PNNs in these disorders may alter rhythms of synaptic plasticity and in turn contribute to shared synaptic deficits ([@B84]; [@B41]; [@B98]; [@B60]). Such deficits may arise from disrupted memory consolidation processes allowing for decreased synaptic formation and/or increased synaptic pruning in brain regions involved in emotional memory processing.

Abnormalities in sleep and circadian rhythms have also been consistently reported in these disorders ([@B68]; [@B65]; [@B82]; [@B97]). Decreased sleep spindles, generated by the TRN, and memory consolidation deficits are emerging as consistent characteristics of schizophrenia ([@B33]; [@B63], [@B64]). Decreased sleep spindles have been reported in several independent studies, including in unmedicated patients with schizophrenia, and in first-degree relatives, suggesting that this represents a core genetic component of the disease rather than medication effects or consequence of disease progression ([@B33]; [@B63], [@B64]). Disruption of WFA+ PNN rhythms in subjects with schizophrenia may contribute to sleep spindle and memory consolidation deficits in several ways. WFA+ PNNs regulate firing rates of neurons expressing PVB, including those in the TRN that generate sleep spindles ([@B26]; [@B52]). Furthermore, decreases of PVB neurons were detected in the TRN of subjects with schizophrenia ([@B105]). PNNs protect PVB neurons from oxidative stress ([@B18]), thus disruption of PNN rhythms may leave PVB neurons more susceptible to accumulation of oxidative damage during sleep, resulting in loss of PVB neurons in subjects with schizophrenia ([@B105]). PVB deficits in TRN function have been proposed by several groups to contribute to memory consolidation deficits in schizophrenia ([@B65]; [@B32]). Disrupted PNN rhythms in the TRN may contribute to a decreased ability of this region to generate sleep spindles and, in turn, memory consolidation deficits. In addition, disrupted PNN rhythm composition by cathepsin-S in expression from microglia in subjects with schizophrenia may contribute to memory consolidation deficits through disruption of local synaptic downscaling and reorganization proposed to occur during sleep ([@B109], [@B110]; [@B90]). Cathepsin-S knock-out mice, in which diurnal rhythms of dendritic spine density were reported ([@B48]), also display deficits in social interaction and novel object recognition ([@B108]), supporting the hypothesis that cathepsin-S rhythms regulate key roles of PNNs in memory processing and social behaviors that are disrupted in subjects with schizophrenia.

Our findings may also be relevant to the pathophysiology of PTSD. PNNs are strongly involved in fear memory processing, which is enhanced in this disorder (for review, see [@B83]; see also [@B42]; [@B8]). Sleep deprivation has been proposed as an early therapeutic approach for PTSD following a traumatic experience ([@B53]; [@B23], [@B24]). Disruption of molecular processes involved in PNN rhythms may represent one of the potential mechanisms through which sleep deprivation may impact memory consolidation as a possible therapeutic approach for alleviating the strength of fear memories contributing to PTSD.

In summary, we provide evidence for diurnal and circadian rhythms of WFA+ PNN numbers in the human and rodent brain, suggesting that their composition is modified on a daily basis. Rhythms in PNN composition may be mediated in part by cathepsin-S expression originating from microglia. These rhythms may contribute to decreased LTP reported during sleep in the hippocampus, suggesting a key process through which multiple cell types including microglia modify PNNs to allow for to memory consolidation.
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Synthesis {#s6}
=========

Reviewing Editor: Cheryl Sisk, Michigan State University

Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. The following reviewer(s) agreed to reveal their identity: Lance Kriegsfeld.

The authors have been very responsive to previous suggestions, adding new experiments, animals, and reconsidering some of the findings. Please address these remaining concerns in a revised manuscript. Most of them can be addressed by more thorough discussion of the limitations of the work, e.g., limited mechanistic insight, lack of strong evidence that effects are mediated by microglia alone, and rewording of the text.

Major

1\. Shifting the emphasis from microglia (including the title) and focusing instead on the daily dynamic of PNNs and effects of sleep is necessary. I see no convincing evidence for the claim of a microglial specific remodeling of the PNN in this manuscript. The presumptive microglial involvement in the PNN variation is not demonstrated satisfactorily (also see points 8, 9 and 10 of the rebuttal letter). In fact, the only available data showing colocalization of CatS to microglia, as co-stained with the pan microglial marker Iba1 (Fig.10 G to I), shows that several cells, which are CatS positive (blue) are NOT microglia (Iba1+, Red). It is not clear to this reviewer how and why the microglia specificity was claimed and how it has been quantified, across different mice and in different brain areas. Furthermore, the images provided do not show an anatomical context (hippocampus), so it is difficult to evaluate whether they are representative of this brain region, and whether or not this statement is more generally validated and quantified.

2\. The point raised by reviewers about any mechanistic insight has also not been addressed by the authors (point 11).

Minor

3\. The first five figures of the manuscript may be easily condensed in one panel, as they are different brain regions within a single dataset; this would simplify reading of the manuscript.

4\. Suggest adding the fear conditioning finding to the abstract.

5\. In the Sleep Deprivation methods, it currently states: 'Mice were either sleep deprived using gentle handling for 5 hours from lights on (7 AM) to 12 PM (n=12) or left undisturbed in normal housing conditions during the light cycle (n=12). Control mice were handled during the dark phase for 5 hours the night before, to control for potential confounding effects of handling on the outcome measures.' I believe the 'undisturbed' portion of the sentence was left over from the previous draft. I would suggest, "Mice were either sleep deprived using gentle handling for 5 hours from lights on (7 AM) to 12 PM (n=12) or handled during the dark phase for 5 hours the night before (controls; n=12), to control for potential confounding effects of handling on the outcome measures."
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